Cite
APA Citation
Furie, R., Parikh, S. V., Maiquez, A., Khan, A., Moreno, O., Soneira, M., Kirk, C., Bomba, D., Harvey, K., & Farmer, M. K. (n.d.). p130 Treatment of SLE with the immunoproteasome inhibitor KZR-616: results from the first 4 cohorts of the MISSION study, an open-label phase 1b dose escalation trial. Lupus science & medicine, 7, A93. http://access.bl.uk/ark:/81055/vdc_100137791609.0x000004